HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Magali Gary-Bobo Selected Research

Mannose (D-Mannose)

7/2020The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics.
10/2019Porphyrin-based bridged silsesquioxane nanoparticles for targeted two-photon photodynamic therapy of zebrafish xenografted with human tumor.
6/2019Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor.
1/2019Mannose 6-phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease.
10/2018Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase.
11/2016Design of Potent Mannose 6-Phosphate Analogues for the Functionalization of Lysosomal Enzymes To Improve the Treatment of Pompe Disease.
2/2016Ruthenium(ii) complex-photosensitized multifunctionalized porous silicon nanoparticles for two-photon near-infrared light responsive imaging and photodynamic cancer therapy.
5/2015Mannose-6-phosphate receptor: a target for theranostics of prostate cancer.
12/2014Two-photon excitation of porphyrin-functionalized porous silicon nanoparticles for photodynamic therapy.
11/2011Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Magali Gary-Bobo Research Topics

Disease

34Neoplasms (Cancer)
05/2022 - 11/2011
31Breast Neoplasms (Breast Cancer)
05/2021 - 03/2009
3Phototoxic Dermatitis (Phototoxicity)
09/2019 - 12/2010
3Prostatic Neoplasms (Prostate Cancer)
06/2019 - 05/2015
3Glycogen Storage Disease Type II (Pompe's Disease)
01/2019 - 11/2016
3Obesity
02/2009 - 02/2006
2Neoplasm Metastasis (Metastasis)
05/2021 - 11/2012
2Inflammation (Inflammations)
09/2017 - 07/2007
2Type 2 Diabetes Mellitus (MODY)
02/2016 - 02/2006
2Colorectal Neoplasms (Colorectal Cancer)
09/2012 - 02/2012
2Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2009 - 07/2007
1Adenocarcinoma
12/2021
1Rhabdomyosarcoma
07/2020
1Colonic Neoplasms (Colon Cancer)
03/2020
1Muscular Diseases (Myopathy)
11/2016
1Diabetes Mellitus
02/2016

Drug/Important Bio-Agent (IBA)

151-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2022 - 03/2009
12Mannose (D-Mannose)IBA
07/2020 - 03/2009
8Pharmaceutical PreparationsIBA
03/2020 - 02/2012
8Silicon Dioxide (Silica)FDA LinkGeneric
06/2019 - 11/2011
7PorphyrinsIBA
05/2022 - 05/2013
5Doxorubicin (Adriamycin)FDA LinkGeneric
03/2020 - 05/2015
4SiliconIBA
07/2020 - 05/2013
4EnzymesIBA
01/2019 - 07/2007
3LigandsIBA
05/2021 - 02/2016
3Small Interfering RNA (siRNA)IBA
07/2020 - 09/2015
3GoldIBA
09/2019 - 01/2015
3Cathepsin DIBA
01/2019 - 12/2012
3GlucosidasesIBA
10/2018 - 02/2016
3Photosensitizing Agents (Photosensitizers)IBA
10/2017 - 02/2012
3CamptothecinIBA
12/2013 - 02/2012
3AdiponectinIBA
02/2009 - 02/2006
3RimonabantIBA
02/2009 - 02/2006
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2021 - 07/2020
2Biological ProductsIBA
07/2020 - 07/2020
2LuciferasesIBA
07/2020 - 09/2019
2AT 760IBA
09/2019 - 09/2016
2CationsIBA
06/2019 - 05/2015
2Peptide Hydrolases (Proteases)FDA Link
01/2019 - 12/2012
2pepstatin (pepstatin A)IBA
01/2019 - 10/2013
2AcidsIBA
10/2018 - 11/2016
2Estrogen ReceptorsIBA
08/2016 - 11/2012
2Bortezomib (Velcade)FDA Link
08/2016 - 11/2012
2Estrogen Receptor Modulators (Antiestrogen)IBA
08/2016 - 11/2012
2Proteasome InhibitorsIBA
08/2016 - 11/2012
2Volatile Oils (Essential Oils)IBA
04/2014 - 02/2014
2Estrogen Receptor alphaIBA
11/2012 - 11/2012
2AdipokinesIBA
02/2009 - 02/2006
1Fluorescent Dyes (Fluorescent Probes)IBA
07/2021
1Singlet OxygenIBA
07/2021
1Chemokine ReceptorsIBA
05/2021
1ChemokinesIBA
05/2021
1Zn(II)-phthalocyanine (zinc phthalocyanine)IBA
04/2021
1TinIBA
04/2021
1Contrast MediaIBA
12/2020
1PolymersIBA
07/2020
1MicellesIBA
03/2020
1ferric ferrocyanide (Prussian blue)FDA Link
01/2020
1EthaneIBA
11/2019
1DiaminesIBA
09/2019
1malonic acid (malonate)IBA
09/2019
1PlatinumIBA
09/2019
1Dendrimers (Dendrons)IBA
03/2019
1Peptides (Polypeptides)IBA
01/2019
1LipopolysaccharidesIBA
09/2017
1Diclofenac (SR 38)FDA LinkGeneric
09/2017
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
08/2016
1Hydroxyl RadicalIBA
08/2016
1Fulvestrant (Faslodex)FDA Link
08/2016
1TamoxifenFDA LinkGeneric
08/2016
1CopperIBA
07/2016
1Alkynes (Acetylenes)IBA
07/2016
1AzidesIBA
07/2016
1mannose-6-phosphateIBA
06/2016
1AcarboseFDA LinkGeneric
02/2016
1Synthetic DrugsIBA
02/2016
1RutheniumIBA
02/2016
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
02/2016
1DisulfidesIBA
08/2015
1rhodamine BIBA
07/2015
1IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
05/2015
1LectinsIBA
05/2015
1Mannose ReceptorIBA
12/2014
1DipeptidesIBA
10/2013
1JMV4463IBA
10/2013
1Aspartic Acid ProteasesIBA
10/2013
1Fluorouracil (Carac)FDA LinkGeneric
09/2013
1ProdrugsIBA
09/2013
1Indicators and Reagents (Reagents)IBA
12/2012
1Cysteine (L-Cysteine)FDA Link
12/2012
1CathepsinsIBA
12/2012
1Cystatin CIBA
12/2012

Therapy/Procedure

16Photochemotherapy (Photodynamic Therapy)
05/2022 - 11/2011
12Therapeutics
07/2021 - 02/2012
6Precision Medicine
07/2021 - 05/2015
4Lasers (Laser)
12/2021 - 09/2016
2Drug Therapy (Chemotherapy)
04/2021 - 03/2020
1Enzyme Therapy
01/2019
1Enzyme Replacement Therapy
10/2018
1Nanospheres
01/2016